Home
CLDI
CLDI News

Latest Calidi Biotherapeutics Inc. (CLDI) News on July 15, 2025

Calidi Biotherapeutics Announces Shareholder Letter from CEO

GlobeNewswire

18 days ago

Calidi Biotherapeutics Announces Shareholder Letter from CEO

Calidi Biotherapeutics Presents systemic oncolytic platform with CD55-Enhanced expression and IL-15 Superagonist Payload at ASCO Annual Meeting

GlobeNewswire

a month ago

Calidi Biotherapeutics Presents systemic oncolytic platform with CD55-Enhanced expression and IL-15 Superagonist Payload at ASCO Annual Meeting

Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights

GlobeNewswire

2 months ago

Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights

Calidi Biotherapeutics Announces IL15 Superagonist as First Payload to be Delivered by Systemic Antitumor Virotherapy Platform at AACR Annual Meeting

GlobeNewswire

3 months ago

Calidi Biotherapeutics Announces IL15 Superagonist as First Payload to be Delivered by Systemic Antitumor Virotherapy Platform at AACR Annual Meeting

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

GlobeNewswire

3 months ago

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Calidi Biotherapeutics Announces Chief Executive Officer Transition and Appointment of Eric Poma, Ph.D. as CEO and Director

GlobeNewswire

3 months ago

Calidi Biotherapeutics Announces Chief Executive Officer Transition and Appointment of Eric Poma, Ph.D. as CEO and Director

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24

GlobeNewswire

3 months ago

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24

Calidi Biotherapeutics Announces FDA Clearance of IND Application for CLD-201 in Solid Tumors

GlobeNewswire

3 months ago

Calidi Biotherapeutics Announces FDA Clearance of IND Application for CLD-201 in Solid Tumors

Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor

GlobeNewswire

3 months ago

Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

GlobeNewswire

3 months ago

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Operational Highlights

GlobeNewswire

3 months ago

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Operational Highlights

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

GlobeNewswire

4 months ago

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Calidi Biotherapeutics and City of Hope Provide Update on a Phase 1 Clinical Trial with CLD-101 Virotherapy in Patients with Recurrent High-Grade Glioma

GlobeNewswire

4 months ago

Calidi Biotherapeutics and City of Hope Provide Update on a Phase 1 Clinical Trial with CLD-101 Virotherapy in Patients with Recurrent High-Grade Glioma

ACCESS Newswire

4 months ago

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

IBN Coverage: Calidi Biotherapeutics (NYSE American: CLDI) Reports Promising Preclinical Results for RTNova Virotherapy Platform

NewMediaWire

4 months ago

IBN Coverage: Calidi Biotherapeutics (NYSE American: CLDI) Reports Promising Preclinical Results for RTNova Virotherapy Platform

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform

GlobeNewswire

4 months ago

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform

Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESS Newswire

5 months ago

Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital

GlobeNewswire

5 months ago

Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5

GlobeNewswire

6 months ago

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement

GlobeNewswire

6 months ago

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement

Calidi Biotherapeutics Announces Presentation of New Data of Systemic Virotherapy RTNova Platform at the AACR Annual Meeting in April 2025

GlobeNewswire

6 months ago

Calidi Biotherapeutics Announces Presentation of New Data of Systemic Virotherapy RTNova Platform at the AACR Annual Meeting in April 2025

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

GlobeNewswire

6 months ago

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

GlobeNewswire

6 months ago

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

Calidi Biotherapeutics Announces Proposed Public Offering

GlobeNewswire

6 months ago

Calidi Biotherapeutics Announces Proposed Public Offering

Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer

GlobeNewswire

8 months ago

Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

GlobeNewswire

8 months ago

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

GlobeNewswire

8 months ago

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

Calidi Biotherapeutics Announces Proposed Public Offering

GlobeNewswire

8 months ago

Calidi Biotherapeutics Announces Proposed Public Offering

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

GlobeNewswire

8 months ago

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESSWIRE

9 months ago

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Calidi to sell 2.05M shares at $1.00 in registered direct offering

TipRanks

9 months ago

Calidi to sell 2.05M shares at $1.00 in registered direct offering

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

GlobeNewswire

9 months ago

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

GlobeNewswire

9 months ago

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Calidi Biotherapeutics Faces Warrant Delisting by NYSE

TipRanks

9 months ago

Calidi Biotherapeutics Faces Warrant Delisting by NYSE

GlobeNewswire

9 months ago

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESSWIRE

9 months ago

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma

GlobeNewswire

10 months ago

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma

Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

GlobeNewswire

a year ago

Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESSWIRE

a year ago

GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

GlobeNewswire

a year ago

Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

GlobeNewswire

a year ago

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board

GlobeNewswire

a year ago

Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board

Calidi to Effect Reverse Stock Split

Business Wire

a year ago

Calidi to Effect Reverse Stock Split

Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors

Business Wire

a year ago

Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors

Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13

Business Wire

a year ago

Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13

Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares

GuruFocus.com

a year ago

Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares

ADM Animal Nutrition Expands Recall to Include Additional Lots of Various Feed Products

Business Wire

a year ago

ADM Animal Nutrition Expands Recall to Include Additional Lots of Various Feed Products

Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares

GuruFocus.com

a year ago

Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares

Factbox-Here's everything Apple announced at WWDC

Reuters

a year ago

Factbox-Here's everything Apple announced at WWDC

Elon Musk's Tesla pay package: More shareholders speak out

Yahoo Finance Video

a year ago

Elon Musk's Tesla pay package: More shareholders speak out

Cargojet enters charter deal for Chinese e-commerce

FreightWaves

a year ago

Cargojet enters charter deal for Chinese e-commerce

Enghouse Releases Second Quarter Results

CNW Group

a year ago

Enghouse Releases Second Quarter Results

AVENUE 8 DOUBLES DOWN ON GENERATIVE AI, SHIFTS FOCUS TO SIDEKICK PLATFORM FOR REAL ESTATE AGENTS

PR Newswire

a year ago

AVENUE 8 DOUBLES DOWN ON GENERATIVE AI, SHIFTS FOCUS TO SIDEKICK PLATFORM FOR REAL ESTATE AGENTS

Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi’s Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors

Business Wire

a year ago

Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi’s Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors

Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting

Business Wire

a year ago

Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting

Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Business Wire

a year ago

Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

ASP Isotopes and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESSWIRE

a year ago

ASP Isotopes and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

ACCESSWIRE

a year ago

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results

Business Wire

a year ago

Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results

Sidoti Events, LLC's Virtual May Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual May Micro-Cap Conference

Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

Business Wire

a year ago

Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24

Business Wire

a year ago

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24

Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering

Business Wire

a year ago

Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering

Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering

Business Wire

a year ago

Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering

Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024

Business Wire

a year ago

Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results

Business Wire

a year ago

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results

Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer

Business Wire

a year ago

Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer

Calidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming Conference

Business Wire

a year ago

Calidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming Conference

Mobix Labs Begins Delivery of Filtered Connectors for Use in the U.S. Navy’s Tomahawk Missile System

Business Wire

a year ago

Mobix Labs Begins Delivery of Filtered Connectors for Use in the U.S. Navy’s Tomahawk Missile System

LexinFintech Holdings Ltd.'s (NASDAQ:LX) most bullish insider is CEO Wenjie Xiao, and their holdings value went up by 14% last week

Simply Wall St.

a year ago

LexinFintech Holdings Ltd.'s (NASDAQ:LX) most bullish insider is CEO Wenjie Xiao, and their holdings value went up by 14% last week

Beware the AI Hype: 3 Stocks to Sell Before They Tumble

InvestorPlace

a year ago

Beware the AI Hype: 3 Stocks to Sell Before They Tumble

GlobeNewswire

a year ago

Diamond Equity Research Releases Update Note on YS Biopharma Co., Ltd. (NASDAQ: YS)

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024

PR Newswire

a year ago

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024

Dividend Challengers List Ranked By Yield: Top 30

Insider Monkey

a year ago

Dividend Challengers List Ranked By Yield: Top 30

We're Keeping An Eye On Brightcove's (NASDAQ:BCOV) Cash Burn Rate

Simply Wall St.

a year ago

We're Keeping An Eye On Brightcove's (NASDAQ:BCOV) Cash Burn Rate

Castor Maritime Inc. Announces the Completion of the Sale of the M/V Magic Moon

GlobeNewswire

a year ago

Castor Maritime Inc. Announces the Completion of the Sale of the M/V Magic Moon

Grove Collaborative Surpasses 15 Million Pounds of Nature-Bound Single-Use Plastic Collected Through Plastic Neutrality Commitment & Partnerships

Business Wire

2 years ago

Grove Collaborative Surpasses 15 Million Pounds of Nature-Bound Single-Use Plastic Collected Through Plastic Neutrality Commitment & Partnerships

Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board

Business Wire

2 years ago

Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board

Business Wire

2 years ago

BP Prudhoe Bay Royalty Trust Announces No Unit Payment for the Fourth Quarter of 2023

Magnachip to Participate in the 26th Annual Needham Growth Conference

PR Newswire

2 years ago

Magnachip to Participate in the 26th Annual Needham Growth Conference

Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire

2 years ago

Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

Lands’ End Announces New Term Loan

GlobeNewswire

2 years ago

Lands’ End Announces New Term Loan

Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections

GlobeNewswire

2 years ago

Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections

Web3 Winners: 3 Stocks to Invest in the Decentralized Web

InvestorPlace

2 years ago

Web3 Winners: 3 Stocks to Invest in the Decentralized Web

Bright Health Group Strengthens Capital Position with Amendment to its Credit Facility, Impending Close of the Sale of its California Medicare Advantage Business

Business Wire

2 years ago

Bright Health Group Strengthens Capital Position with Amendment to its Credit Facility, Impending Close of the Sale of its California Medicare Advantage Business

12 Most Profitable Pot Stocks Now

Insider Monkey

2 years ago

12 Most Profitable Pot Stocks Now

Riverview Bancorp Declares Quarterly Cash Dividend of $0.06 Per Share

GlobeNewswire

2 years ago

Riverview Bancorp Declares Quarterly Cash Dividend of $0.06 Per Share

7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight

InvestorPlace

2 years ago

7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight

Those who invested in Abeona Therapeutics (NASDAQ:ABEO) a year ago are up 98%

Simply Wall St.

2 years ago

Those who invested in Abeona Therapeutics (NASDAQ:ABEO) a year ago are up 98%

7 Under-the-Radar Stocks Gearing Up for a 2025 Breakthrough

InvestorPlace

2 years ago

7 Under-the-Radar Stocks Gearing Up for a 2025 Breakthrough

Stronghold Digital Mining, Inc. (NASDAQ:SDIG) Stock Rockets 26% But Many Are Still Ignoring The Company

Simply Wall St.

2 years ago

Stronghold Digital Mining, Inc. (NASDAQ:SDIG) Stock Rockets 26% But Many Are Still Ignoring The Company

What Makes Invitae (NVTA) a New Buy Stock

Zacks

2 years ago

What Makes Invitae (NVTA) a New Buy Stock

Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit

Business Wire

2 years ago

Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit

Calidi Biotherapeutics Announces Appointment of Pharmaceutical Industry Veteran David LaPré to its Board of Directors

Business Wire

2 years ago

Calidi Biotherapeutics Announces Appointment of Pharmaceutical Industry Veteran David LaPré to its Board of Directors

What Makes Corvus (CRVS) a New Buy Stock

Zacks

2 years ago

What Makes Corvus (CRVS) a New Buy Stock

Business Wire

2 years ago

Volato Launches Partner Benefits Program to Provide Elevated Luxury Experiences for Members

While institutions invested in Sera Prognostics, Inc. (NASDAQ:SERA) benefited from last week's 183% gain, retail investors stood to gain the most

Simply Wall St.

2 years ago

While institutions invested in Sera Prognostics, Inc. (NASDAQ:SERA) benefited from last week's 183% gain, retail investors stood to gain the most

Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine

PR Newswire

2 years ago

Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine

Insider Sell: President and COO Brian Olschan Sells 12,054 Shares of Acme United Corp (ACU)

GuruFocus.com

2 years ago

Insider Sell: President and COO Brian Olschan Sells 12,054 Shares of Acme United Corp (ACU)

Ondas Holdings to Present at Oppenheimer 4th Annual 5G Summit: The Revolution Continues, on December 11, 2023

ACCESSWIRE

2 years ago

Ondas Holdings to Present at Oppenheimer 4th Annual 5G Summit: The Revolution Continues, on December 11, 2023

Share on Social Networks: